Aurora Cannabis (ACB) Gains from Equity Investments (2017 - 2025)

Aurora Cannabis (ACB) has reported Gains from Equity Investments for 9 consecutive years, with $33.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gains from Equity Investments rose 6.75% year-over-year to $33.1 million; the TTM figure through Dec 2025 stood at $116.0 million (up 21.16% YoY), while the FY2023 annual figure was $10.9 million, up 59.41% from the prior year.
• Gains from Equity Investments advanced to $33.1 million in Q4 2025 per ACB's latest filing, from $25.9 million in the prior quarter.
• Across five years, Gains from Equity Investments topped out at $33.1 million in Q4 2025 and bottomed at -$57.2 million in Q1 2021.
• Historically, Gains from Equity Investments has averaged $10.6 million across 5 years, with a median of $15.1 million in 2023.
• Annual changes were most pronounced in 2021 — Gains from Equity Investments tumbled 340.45% — and 2022, when it jumped 190.29%.
• Aurora Cannabis' Gains from Equity Investments stood at -$8.8 million in 2021, then soared by 190.29% to $7.9 million in 2022, then soared by 90.73% to $15.1 million in 2023, then jumped by 105.12% to $31.0 million in 2024, then gained by 6.75% to $33.1 million in 2025.
• Business Quant data shows ACB's Gains from Equity Investments at $33.1 million in Q4 2025, $25.9 million in Q3 2025, and $26.0 million in Q2 2025.